STEERLife Redefines Potent Drug Development with Clean, Green, Continuous Processing

STEERLife, the life sciences division of STEER World, is advancing the development and manufacturing of potent and complex drug products. This initiative marks a significant advancement in a field that has long been considered

JB Pharma sets Asia Book of Record for Highest MICRAL conducted for Hypertension Patients in India

JB Pharma is making significant strides in the fight against hypertension and its impact on kidney health, in India. On the occasion of the upcoming ‘World Hypertension Day’ celebrated on 17th May

Trump's Executive Order on MFN Drugs to Boost Generics & Biosimilars Adoption

U.S. President Donald Trump's Executive Order on Most Favored Nation (MFN), proposed to reduce prescription drug cost inequalities.

LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports

LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup ExportsThe Laghu Udyog Bharati which supports small-scale industries, have requested the government to lift the requirement that the cough syrups be analyzed at government-approved...

Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy

Hoth Therapeutics Unveils Promising Data for KIT-Targeting TherapyHoth Therapeutics Inc, a clinical stage biopharmaceutical company, also dedicated to novel medical needs, has reported very promising data of preclinical efficacy...

GSK, iTeos Drop Lung Cancer Drug After Ineffective Trial Results

British pharmaceutical company GSK and iTeos Therapeutics announced on Tuesday that they had halted the development of belrestotug, an experimental treatment for lung cancer, after two tests showed that it was ineffective in halting the disease's pro

India Tops Global Charts for CDMO Appeal, Says LoEstro Study

India is fast developing as the world’s most attractive landscaping destination for contract development and manufacturing organization.

Glaxosmithkline Pharmaceuticals Posts 34.7% Surge in Q4 Net Profit

The net profit of Glaxosmithkline pharmaceuticals has been raised to 34.73 percent in the quarter of March 2025.

Cipla Says Indian Generics Safe from US Pricing Rule

Cipla Says Indian Generics Safe from US Pricing RuleCipla Global CEO and Managing Director Umang Vohra stated that the recent US government directive ordering pharma firms to reduce the price of prescription medicine in 30 days is not likely to...

Piramal Pharma to Invest USD 90 Million in Expanding US Facilities

Piramal Pharma to Invest USD 90 Million in Expanding US FacilitiesMumbai-based Piramal Pharma Limited has made a USD 90 million investment to build out two of its facilities in the US. The announcement comes on the backdrop of the 2025 Select USA...

© 2025 India Pharma Outlook. All Rights Reserved.